傑克股份(603337.SH):2017年員工持股計劃股票出售完畢
格隆匯6月3日丨傑克股份(603337.SH)公佈,公司2017年員工持股計劃於2017年9月22日完成股票購買,通過二級市場買入方式增持公司股票794.10萬股,佔公司已發行股本3.84%。成交合計金額3.17億元,成交均價39.95元。上述購買的股票按照規定予以鎖定,鎖定期為2017年9月22日起12個月。公司2017年員工持股計劃的存續期為48個月,自股東大會審議通過之日起計算。
截至本公吿披露日,公司2017年員工持股計劃所持有的公司股份股票通過二級市場已全部出售完畢。根據相關規定,公司2017年員工持股計劃已實施完畢並終止,後續將進行相關財產清算和分配等工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.